Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MGTX |
---|---|---|
09:32 ET | 1316 | 4.98 |
09:34 ET | 200 | 4.995 |
09:36 ET | 1323 | 5.025 |
09:38 ET | 501 | 5.025 |
09:39 ET | 200 | 5.005 |
09:43 ET | 100 | 5.02 |
09:45 ET | 100 | 5.11 |
09:52 ET | 100 | 5.1 |
09:54 ET | 250 | 5.11 |
09:57 ET | 100 | 5.1 |
10:01 ET | 1242 | 5.005 |
10:10 ET | 230 | 5.015 |
10:12 ET | 100 | 5.03 |
10:17 ET | 400 | 5.03 |
10:21 ET | 350 | 5.0208 |
10:24 ET | 500 | 5.05 |
10:26 ET | 431 | 5.03 |
10:30 ET | 2592 | 5.01 |
10:32 ET | 500 | 5.01 |
10:33 ET | 502 | 4.98 |
10:35 ET | 1800 | 4.96 |
10:39 ET | 700 | 4.98 |
10:44 ET | 100 | 4.97 |
10:48 ET | 500 | 4.96 |
10:50 ET | 300 | 4.95 |
10:53 ET | 200 | 4.95 |
10:55 ET | 100 | 4.95 |
10:57 ET | 197 | 4.9912 |
11:00 ET | 300 | 4.95 |
11:06 ET | 1550 | 4.92 |
11:09 ET | 600 | 4.92 |
11:11 ET | 200 | 4.945 |
11:13 ET | 711 | 4.92 |
11:20 ET | 100 | 4.92 |
11:24 ET | 100 | 4.92 |
11:26 ET | 4686 | 4.945 |
11:27 ET | 300 | 4.945 |
11:29 ET | 100 | 4.945 |
11:31 ET | 300 | 4.95 |
11:33 ET | 100 | 4.92 |
11:36 ET | 3629 | 4.94 |
11:38 ET | 5646 | 4.9 |
11:40 ET | 1900 | 4.905 |
11:42 ET | 100 | 4.91 |
11:44 ET | 4200 | 4.94 |
11:45 ET | 300 | 4.895 |
11:47 ET | 2100 | 4.91 |
11:49 ET | 200 | 4.925 |
11:56 ET | 1800 | 4.95 |
12:00 ET | 1300 | 4.92 |
12:02 ET | 500 | 4.935 |
12:05 ET | 300 | 4.91 |
12:07 ET | 100 | 4.895 |
12:12 ET | 2400 | 4.9 |
12:18 ET | 202 | 4.9 |
12:20 ET | 400 | 4.9 |
12:21 ET | 1962 | 4.9 |
12:23 ET | 7637 | 4.92 |
12:25 ET | 144 | 4.9037 |
12:27 ET | 100 | 4.92 |
12:36 ET | 100 | 4.94 |
12:38 ET | 1900 | 4.915 |
12:39 ET | 100 | 4.92 |
12:41 ET | 100 | 4.93 |
12:54 ET | 1594 | 4.91 |
12:56 ET | 200 | 4.925 |
12:57 ET | 300 | 4.96 |
01:01 ET | 500 | 4.945 |
01:03 ET | 100 | 4.945 |
01:06 ET | 100 | 4.945 |
01:10 ET | 100 | 4.93 |
01:15 ET | 100 | 4.92 |
01:17 ET | 100 | 4.92 |
01:19 ET | 300 | 4.9 |
01:21 ET | 600 | 4.92 |
01:26 ET | 100 | 4.91 |
01:30 ET | 300 | 4.92 |
01:33 ET | 200 | 4.915 |
01:37 ET | 100 | 4.92 |
01:39 ET | 100 | 4.91 |
01:44 ET | 7364 | 4.9 |
01:48 ET | 300 | 4.89 |
01:50 ET | 400 | 4.92 |
01:51 ET | 1100 | 4.93 |
01:55 ET | 100 | 4.92 |
02:02 ET | 300 | 4.91 |
02:04 ET | 100 | 4.92 |
02:06 ET | 100 | 4.9 |
02:08 ET | 400 | 4.89 |
02:09 ET | 2400 | 4.91 |
02:11 ET | 400 | 4.91 |
02:13 ET | 3200 | 4.91 |
02:15 ET | 447 | 4.89 |
02:18 ET | 100 | 4.92 |
02:24 ET | 3500 | 4.95 |
02:26 ET | 1850 | 4.945 |
02:27 ET | 500 | 4.945 |
02:33 ET | 102 | 4.93 |
02:36 ET | 8988 | 4.925 |
02:38 ET | 600 | 4.925 |
02:40 ET | 300 | 4.925 |
02:42 ET | 100 | 4.91 |
02:49 ET | 200 | 4.91 |
02:51 ET | 861 | 4.91 |
02:54 ET | 1212 | 4.89 |
02:56 ET | 2394 | 4.895 |
02:58 ET | 800 | 4.92 |
03:02 ET | 2270 | 4.91 |
03:03 ET | 100 | 4.9 |
03:14 ET | 200 | 4.88 |
03:16 ET | 281 | 4.86 |
03:18 ET | 100 | 4.87 |
03:20 ET | 100 | 4.87 |
03:21 ET | 316 | 4.86 |
03:25 ET | 200 | 4.86 |
03:27 ET | 180 | 4.86 |
03:30 ET | 394 | 4.86 |
03:34 ET | 200 | 4.86 |
03:36 ET | 360 | 4.86 |
03:38 ET | 14842 | 4.88 |
03:39 ET | 200 | 4.86 |
03:41 ET | 1300 | 4.87 |
03:43 ET | 6270 | 4.87 |
03:45 ET | 2412 | 4.87 |
03:48 ET | 5432 | 4.87 |
03:50 ET | 1200 | 4.85 |
03:52 ET | 2236 | 4.86 |
03:54 ET | 2700 | 4.87 |
03:56 ET | 3560 | 4.87 |
03:57 ET | 948 | 4.88 |
03:59 ET | 23684 | 4.9 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
MeiraGTx Holdings PLC | 315.1M | -3.8x | --- |
C4 Therapeutics Inc | 344.0M | -2.1x | --- |
XOMA Corp | 300.2M | -6.6x | --- |
Uniqure NV | 240.3M | -0.8x | --- |
Solid Biosciences Inc | 317.0M | -2.1x | --- |
Q32 Bio Inc | 304.5M | -1.0x | --- |
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage gene therapy company. The Company is focused on three distinct areas of unmet medical need: ocular diseases, including inherited retinal diseases (IRDs), as well as large degenerative ocular diseases, severe forms of xerostomia and neurodegenerative diseases. Its product pipeline includes botaretigene sparoparvovec or bota-vec, for the treatment of X-linked retinitis pigmentosa related to mutations in the retinitis pigmentosa GTPase regulator gene or XLRP-RPGR; AAV-hAQP1 for the treatment of radiation-induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-asociated retinal dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of achromatopsia; AAV-AIPL1 for the treatment of LCA4, and AAV-RDH12 for the treatment of RDH12 mutation-associated retinal dystrophy.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $315.1M |
---|---|
Revenue (TTM) | $11.4M |
Shares Outstanding | 64.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.42 |
EPS | $-1.27 |
Book Value | $2.17 |
P/E Ratio | -3.8x |
Price/Sales (TTM) | 27.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,336.32% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.